KLK3 and carcinoma: The only organs that remain a diagnostic challenge for 18FDG-PET/CT are the colon, breast, stomach, urinary tract and the carcinomas for which there are specific tumour markers [prostate-specific antigen (PSA), alpha fetoprotein (AFP), calcitonin, chromogranin A].